Associate Professor at Ilam University of Medical Science, Iran
Dr. Hassan Nourmohammadi is an Associate Professor of Oncology, Hematology, and Bone Marrow Transplantation at the Non-Communicable Diseases Research Center, Ilam University of Medical Sciences. His academic journey and clinical expertise reflect a deep commitment to advancing the fields of internal medicine, hematology, and oncology. With a focus on treating complex conditions such as blood cancers and hematological disorders, he has contributed significantly to both medical education and patient care. Beyond his clinical practice, Dr. Nourmohammadi has engaged in impactful research spanning cancer treatment, stem cell transplantation, and infectious diseases. His scholarly contributions include original articles, systematic reviews, and innovative vaccine design through immunoinformatics. A respected educator, he has taught numerous medical courses and guided students across different medical disciplines. Through his academic leadership, clinical service, and international collaborations, Dr. Nourmohammadi continues to shape advancements in oncology and hematology while mentoring future medical professionals.
Professional Profile
Google Scholar
Education
Dr. Hassan Nourmohammadi pursued his medical education across leading universities in Iran, building a strong foundation in medical sciences. He began his academic path at Isfahan University of Medical Sciences, where he completed his training as a general practitioner. His interest in internal medicine led him to Mazandaran University of Medical Sciences, where he earned board certification as a specialist in internal medicine. Driven by a passion for oncology and hematology, he advanced his studies at Tehran University of Medical Sciences, where he completed his subspecialty board in oncology, hematology, and bone marrow transplantation. These academic achievements provided him with both theoretical knowledge and practical expertise in diagnosing and treating complex medical conditions. His educational journey reflects a strong dedication to medicine and patient care, laying the groundwork for his role as a clinician, researcher, and academic mentor in hematology, oncology, and advanced cancer therapies.
Experience
Dr. Hassan Nourmohammadi has extensive experience in clinical practice, academic teaching, and advanced medical research. As an Associate Professor at Ilam University of Medical Sciences, he has led the Non-Communicable Diseases Research Center and contributed to developing innovative treatments for blood cancers and hematological disorders. His clinical work includes performing bone marrow and stem cell transplantations for patients with conditions such as multiple myeloma, acute leukemia, thalassemia, and lymphomas. Alongside clinical responsibilities, he has taught a wide range of medical courses, including internal medicine, hematology, gastroenterology, endocrinology, and respiratory system studies. His experience extends to supervising theses, guiding research projects, and contributing to international collaborations in oncology and hematology. Dr. Nourmohammadi has also published extensively in peer-reviewed journals, adding to the global body of medical knowledge. His professional journey highlights his dual role as a skilled clinician and dedicated academic shaping the future of medical science.
Research Focus
Dr. Hassan Nourmohammadi’s research spans oncology, hematology, stem cell transplantation, and internal medicine, with a strong emphasis on improving cancer treatment outcomes. His work has explored innovative therapeutic approaches in advanced cancers, the complications of stem cell transplantation, and supportive care for patients with blood disorders. He has also contributed significantly to global health research through systematic reviews and meta-analyses on conditions such as osteoporosis, hepatitis, gastroesophageal reflux disease, and COVID-19. His interest in immunoinformatics has led to the design of multi-epitope vaccine candidates targeting infectious diseases including leishmaniasis, toxoplasmosis, and echinococcosis. Additionally, his studies have examined psychological and supportive therapies, such as mindfulness and cognitive behavioral interventions, for patients and caregivers affected by cancer. This diverse body of research reflects his integrative approach, bridging clinical oncology with innovative biomedical science to advance both patient-centered care and future therapeutic strategies.
Publication Top Notes
Title: Positive effects of cognitive behavioral therapy on depression, anxiety and stress of family caregivers of patients with prostate cancer: A randomized clinical trial
Journal: Asian Pacific Journal of Cancer Prevention (APJCP)
Summary: This study evaluated the effectiveness of cognitive behavioral therapy in reducing depression, anxiety, and stress among family caregivers of prostate cancer patients. Results confirmed that CBT significantly improved psychological well-being, highlighting its value as a supportive intervention.
Title: Investigating the effect of mindfulness-based training on psychological status and quality of life in patients with breast cancer
Journal: Asian Pacific Journal of Cancer Prevention (APJCP)
Summary: The research explored how mindfulness training influences the psychological health and quality of life of breast cancer patients. Findings indicated that mindfulness practices improved emotional stability and overall quality of life, offering a useful complementary therapy.
Title: Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis
Journal: BMC Gastroenterology
Summary: This systematic review and meta-analysis examined the prevalence of gastroesophageal reflux disease (GERD) in Iran. It provided comprehensive epidemiological data, helping inform public health strategies for diagnosis, treatment, and prevention.
Title: The effects of reflexology on fatigue severity of patients with cancer
Journal: Asian Pacific Journal of Cancer Prevention (APJCP)
Summary: The study investigated reflexology as a supportive therapy for cancer patients experiencing fatigue. Results showed a reduction in fatigue severity, suggesting reflexology as an effective complementary care approach.
Title: Leishmanolysin gp63: Bioinformatics evidences of immunogenic epitopes in Leishmania major for enhanced vaccine design against zoonotic cutaneous leishmaniasis
Journal: Informatics in Medicine Unlocked
Summary: Using bioinformatics tools, this study identified immunogenic epitopes within Leishmanolysin gp63 of Leishmania major. These findings contribute to the development of improved vaccine designs for zoonotic cutaneous leishmaniasis.
Title: Bioinformatics features and immunogenic epitopes of Echinococcus granulosus Myophilin as a promising target for vaccination against cystic echinococcosis
Journal: Infection, Genetics and Evolution
Summary: The research analyzed bioinformatics features and immunogenic epitopes of Echinococcus granulosus Myophilin. It proposed Myophilin as a strong vaccine candidate against cystic echinococcosis.
Title: Multi-epitope vaccine against cystic echinococcosis using immunodominant epitopes from EgA31 and EgG1Y162 antigens
Journal: Informatics in Medicine Unlocked
Summary: This study developed a multi-epitope vaccine model combining epitopes from EgA31 and EgG1Y162 antigens. Findings showed promising potential for designing effective vaccines against cystic echinococcosis.
Conclusion
Dr. Hassan Nourmohammadi exemplifies the integration of clinical expertise, academic leadership, and research innovation in oncology and hematology. His work as a physician-scientist demonstrates a balanced dedication to patient care, medical education, and scientific advancement. By performing complex bone marrow and stem cell transplantations, he has directly improved the lives of patients with life-threatening diseases. As an academic, he has mentored students across various medical disciplines, ensuring the growth of future generations of physicians and researchers. His prolific research output, covering both clinical and bioinformatics-based studies, has contributed valuable insights to cancer treatment, infectious diseases, and immunology. Membership in esteemed international medical organizations highlights his active engagement in global health dialogues. Through his continuous contributions, Dr. Nourmohammadi strengthens the bridge between science and practice, reaffirming his role as a respected leader in oncology, hematology, and advanced medical research.